Selected CGRP antagonists, methods for the production thereof and their use as medicaments

Details for Australian Patent Application No. 2005225539 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Lustenberger, Philipp; Dreyer, Alexander; Rudolf, Klaus; Santagostino, Marco; Doods, Henri; Mueller, Stephan Georg; Schaenzle, Gerhard; Paleari, Fabio; Arndt, Kirsten; Stenkamp, Dirk

Agent Davies Collison Cave

Pub. Number AU-A-2005225539

PCT Pub. Number WO2005/092880

Priority DE 10 2004 015 723.5 29.03.04 DE

Filing date 23 March 2005

Wipo publication date 6 October 2005

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/092880 Priority application(s): WO2005/092880

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005225559-Novel urea derivatives and their medical use

2005225525-Methods and means for nucleic acid sequencing